INmune Bio, Inc. (INMB)
1.23
+0.02
(+1.65%)
USD |
NASDAQ |
Jun 11, 11:34
INmune Bio Market Cap : 32.70M for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 32.17M |
| June 09, 2026 | 32.43M |
| June 08, 2026 | 32.97M |
| June 05, 2026 | 33.50M |
| June 04, 2026 | 35.89M |
| June 03, 2026 | 35.09M |
| June 02, 2026 | 37.75M |
| June 01, 2026 | 36.95M |
| May 29, 2026 | 37.49M |
| May 28, 2026 | 37.75M |
| May 27, 2026 | 37.22M |
| May 26, 2026 | 38.02M |
| May 22, 2026 | 38.55M |
| May 21, 2026 | 38.28M |
| May 20, 2026 | 37.49M |
| May 19, 2026 | 37.49M |
| May 18, 2026 | 39.61M |
| May 15, 2026 | 41.21M |
| May 14, 2026 | 44.66M |
| May 13, 2026 | 38.81M |
| May 12, 2026 | 36.95M |
| May 11, 2026 | 35.89M |
| May 08, 2026 | 38.02M |
| May 07, 2026 | 38.02M |
| May 06, 2026 | 40.41M |
| Date | Value |
|---|---|
| May 05, 2026 | 40.94M |
| May 04, 2026 | 39.35M |
| May 01, 2026 | 40.14M |
| April 30, 2026 | 38.02M |
| April 29, 2026 | 35.36M |
| April 28, 2026 | 37.22M |
| April 27, 2026 | 39.08M |
| April 24, 2026 | 36.95M |
| April 23, 2026 | 36.69M |
| April 22, 2026 | 38.02M |
| April 21, 2026 | 36.42M |
| April 20, 2026 | 39.61M |
| April 17, 2026 | 38.55M |
| April 16, 2026 | 35.62M |
| April 15, 2026 | 35.09M |
| April 14, 2026 | 33.50M |
| April 13, 2026 | 32.97M |
| April 10, 2026 | 31.37M |
| April 09, 2026 | 34.03M |
| April 08, 2026 | 34.30M |
| April 07, 2026 | 33.76M |
| April 06, 2026 | 32.70M |
| April 02, 2026 | 32.17M |
| April 01, 2026 | 32.70M |
| March 31, 2026 | 30.04M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sangamo Therapeutics, Inc. | 61.73M |
| Arrowhead Pharmaceuticals, Inc. | 10.43B |
| Oncolytics Biotech, Inc. | 92.86M |
| Sarepta Therapeutics, Inc. | 1.581B |
| Anixa Biosciences, Inc. | 84.66M |
Market Cap Related Metrics
| Price to Book Value | 1.666 |
| Price | 1.23 |
| Earnings Yield | -137.8% |